WallStreetZenWallStreetZen

NASDAQ: SIEN
Sientra Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for SIEN

Based on 3 analysts offering 12 month price targets for Sientra Inc.
Min Forecast
$7.00+2,492.59%
Avg Forecast
$7.67+2,739.63%
Max Forecast
$8.00+2,862.96%

Should I buy or sell SIEN stock?

Based on 4 analysts offering ratings for Sientra Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
0 analysts 0%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SIEN stock forecasts and price targets.

SIEN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
William Blair
Bottom 12%
12
HoldDowngradesN/AN/A2022-10-25
Lake Street
Bottom 17%
17
Strong BuyInitiates Coverage On$8.00+2,862.96%2022-04-14
Canaccord Genuity
Top 12%
89
Strong BuyMaintains$8.00+2,862.96%2022-03-29
Stifel Nicolaus
Bottom 13%
13
Strong BuyMaintains$7.00+2,492.59%2022-03-24

1 of 1

Forecast return on equity

Is SIEN forecast to generate an efficient return?

Forecast return on assets

Is SIEN forecast to generate an efficient return on assets?
Company
-18.26%
Industry
10.51%
SIEN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SIEN earnings per share forecast

What is SIEN's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.95
Avg 2 year Forecast
-$0.74
Avg 3 year Forecast
-$0.30

SIEN revenue forecast

What is SIEN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$93.1M+5.58%
Avg 2 year Forecast
$114.7M+30.15%
Avg 3 year Forecast
$135.7M+53.98%
SIEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SIEN revenue growth forecast

How is SIEN forecast to perform vs Medical Devices companies and vs the US market?
Company
13.99%
Industry
4.02%
Market
6.42%
SIEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SIEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SIEN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SIEN$0.27$7.67+2,739.63%Strong Buy
EAR$0.71$10.00+1,314.43%Sell
CFMS$3.52$8.00+127.27%Buy
DCTH$3.34$19.50+483.83%Strong Buy
AFIB$0.91$2.00+120.75%Buy

Sientra Stock Forecast FAQ

Is Sientra Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: SIEN) stock is to Strong Buy SIEN stock.

Out of 4 analysts, 3 (75%) are recommending SIEN as a Strong Buy, 0 (0%) are recommending SIEN as a Buy, 1 (25%) are recommending SIEN as a Hold, 0 (0%) are recommending SIEN as a Sell, and 0 (0%) are recommending SIEN as a Strong Sell.

If you're new to stock investing, here's how to buy Sientra stock.

What is SIEN's earnings growth forecast for 2022-2024?

(NASDAQ: SIEN) Sientra's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 33.55%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.2%.

Sientra's earnings in 2022 is -$67,394,000.On average, 3 Wall Street analysts forecast SIEN's earnings for 2022 to be -$95,946,114, with the lowest SIEN earnings forecast at -$100,995,909, and the highest SIEN earnings forecast at -$93,926,195. On average, 3 Wall Street analysts forecast SIEN's earnings for 2023 to be -$74,736,973, with the lowest SIEN earnings forecast at -$97,966,032, and the highest SIEN earnings forecast at -$52,517,873.

In 2024, SIEN is forecast to generate -$30,298,773 in earnings, with the lowest earnings forecast at -$30,298,773 and the highest earnings forecast at -$30,298,773.

What is SIEN's revenue growth forecast for 2022-2024?

(NASDAQ: SIEN) Sientra's forecast annual revenue growth rate of 13.99% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.02%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.42%.

Sientra's revenue in 2022 is $88,129,000.On average, 2 Wall Street analysts forecast SIEN's revenue for 2022 to be $9,397,669,332, with the lowest SIEN revenue forecast at $9,160,328,946, and the highest SIEN revenue forecast at $9,635,009,719. On average, 2 Wall Street analysts forecast SIEN's revenue for 2023 to be $11,584,230,762, with the lowest SIEN revenue forecast at $11,281,243,035, and the highest SIEN revenue forecast at $11,887,218,489.

In 2024, SIEN is forecast to generate $13,705,144,851 in revenue, with the lowest revenue forecast at $13,705,144,851 and the highest revenue forecast at $13,705,144,851.

What is SIEN's forecast return on assets (ROA) for 2022-2024?

(NASDAQ: SIEN) forecast ROA is -18.26%, which is lower than the forecast US Medical Devices industry average of 10.51%.

What is SIEN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SIEN price target, the average SIEN price target is $7.67, with the highest SIEN stock price forecast at $8.00 and the lowest SIEN stock price forecast at $7.00.

On average, Wall Street analysts predict that Sientra's share price could reach $7.67 by Oct 25, 2023. The average Sientra stock price prediction forecasts a potential upside of 2,739.63% from the current SIEN share price of $0.27.

What is SIEN's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: SIEN) Sientra's current Earnings Per Share (EPS) is -$1.10. On average, analysts forecast that SIEN's EPS will be -$0.95 for 2022, with the lowest EPS forecast at -$1.00, and the highest EPS forecast at -$0.93. On average, analysts forecast that SIEN's EPS will be -$0.74 for 2023, with the lowest EPS forecast at -$0.97, and the highest EPS forecast at -$0.52. In 2024, SIEN's EPS is forecast to hit -$0.30 (min: -$0.30, max: -$0.30).

What is SIEN's forecast return on equity (ROE) for 2022-2024?

(NASDAQ: SIEN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.